SILVER SPRING
Lerochol autoinjector cleared, indication updated
- Sponsor
- LIB Therapeutics, Inc.
- Drug
- Lerochol · lerodalcibep-liga
- Indication
- lowering cholesterol
FDA approves an autoinjector version of lerodalcibep-liga and updates its indication for lowering cholesterol.
What this means
Lerochol is a cholesterol-lowering drug that works by blocking a liver protein called PCSK9, which helps remove "bad" cholesterol from the blood. The FDA has now cleared a pre-filled autoinjector version of the drug for patient use and updated its official indication. This makes the treatment more convenient for people with high cholesterol who need long-term medication.
Drug Watch — recent news on Lerochol
- Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia - BioSpectrum Asia
- Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia - BioSpectrum Asia
- Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia - BioSpectrum Asia
- Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia - BioSpectrum Asia
- Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia - BioSpectrum Asia